FDA Clearance Tracker · P160054-S039
HeartMate 3 Left Ventricular Assist System
Last checked: Nov 20, 2026Latest source record: Mar 24, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Mar 24, 2022
Approved
Time to decision
178 days
Received Sep 27, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P160054-S039
- Device name
- HeartMate 3 Left Ventricular Assist System
- Applicant
- ABBOTT MEDICAL
- Applicant location
- Pleasanton, CA
- Received
- Sep 27, 2021
- Decided
- Mar 24, 2022
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - PAS
- Original approval
- P160054
Device type
- Device type
- Ventricular (assist) bypass (DSQ)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval for various updates to the Instructions for Use to add the final clinical results of the Long-Term Durability Cohort of the pivotal trial and of the post-approval study entitled "Continued Follow-up of the Continued Access Cohort."
Source documents
Other decisions for ABBOTT MEDICAL
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.